Lumosity

Lumosity is a San Francisco-based developer of cognitive training games and digital health software, operated by Lumos Labs, Inc. Its work combines game development with cognitive neuroscience, creating web and mobile experiences built around mental abilities such as memory, attention, cognitive flexibility, processing speed, and problem solving.

Founded in 2005, the company launched its commercial Lumosity platform in 2007 after two years of research and development. The platform has grown into a collection of more than 50 cognitive games available through web browsers, iOS, and Android, reaching more than 100 million registered users worldwide. Its consumer business centres on subscription access to adaptive brain training activities.

Games and cognitive assessment

The studio brings together game developers, artists, and cognitive neuroscientists to translate traditional neuropsychological paradigms into accessible interactive tasks. Its capabilities span game design, software engineering, adaptive difficulty algorithms, and neuropsychological assessment. The resulting activities address several cognitive domains, including working memory and selective attention, alongside mathematical and problem-solving exercises.

Beyond its flagship training platform, the company develops Lumosity Mind, a guided meditation and mindfulness app with daily exercises and habit tracking. Its creative drawing title Figment by Lumosity explores imagination and artistic puzzle play, extending the portfolio beyond conventional cognitive workouts.

Research and digital medicine

Lumos Labs also operates the Human Cognition Project, an academic collaboration initiative that makes its cognitive tasks and assessments available for scientific research. This research activity sits alongside the company's consumer game development and its work in prescription digital therapeutics.

The company's expansion into digital medicine includes Prismira, a prescription digital therapeutic software program for ADHD that received FDA 510(k) clearance in June 2025. Together, its consumer games, assessment software, research collaborations, and therapeutic development reflect an operating focus spanning interactive entertainment, cognitive science, and digital health. The company continues developing its game portfolio while pursuing these related applications of cognitive software.